MapLight Therapeutics, Inc. (MPLT)
30.27
+2.47
(+8.88%)
USD |
NASDAQ |
Jun 11, 16:00
30.27
0.00 (0.00%)
After-Hours: 17:14
MapLight Therapeutics Enterprise Value : 952.29M for June 10, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 10, 2026 | 952.29M |
| June 09, 2026 | 1.019B |
| June 08, 2026 | 1.027B |
| June 05, 2026 | 961.78M |
| June 04, 2026 | 1.056B |
| June 03, 2026 | 976.70M |
| June 02, 2026 | 931.49M |
| June 01, 2026 | 1.041B |
| May 29, 2026 | 1.021B |
| May 28, 2026 | 1.042B |
| May 27, 2026 | 1.035B |
| May 26, 2026 | 1.031B |
| May 22, 2026 | 999.17M |
| May 21, 2026 | 1.023B |
| May 20, 2026 | 956.54M |
| May 19, 2026 | 923.44M |
| May 18, 2026 | 897.14M |
| May 15, 2026 | 998.26M |
| May 14, 2026 | 1.024B |
| May 13, 2026 | 1.086B |
| May 12, 2026 | 1.069B |
| May 11, 2026 | 1.060B |
| May 08, 2026 | 937.95M |
| May 07, 2026 | 1.020B |
| May 06, 2026 | 1.012B |
| Date | Value |
|---|---|
| May 05, 2026 | 961.30M |
| May 04, 2026 | 992.59M |
| May 01, 2026 | 1.087B |
| April 30, 2026 | 1.140B |
| April 29, 2026 | 1.069B |
| April 28, 2026 | 1.070B |
| April 27, 2026 | 1.085B |
| April 24, 2026 | 1.041B |
| April 23, 2026 | 1.012B |
| April 22, 2026 | 1.148B |
| April 21, 2026 | 944.15M |
| April 20, 2026 | 976.70M |
| April 17, 2026 | 1.054B |
| April 16, 2026 | 984.38M |
| April 15, 2026 | 911.60M |
| April 14, 2026 | 917.02M |
| April 13, 2026 | 884.92M |
| April 10, 2026 | 903.91M |
| April 09, 2026 | 1.025B |
| April 08, 2026 | 791.34M |
| April 07, 2026 | 786.82M |
| April 06, 2026 | 717.65M |
| April 02, 2026 | 652.55M |
| April 01, 2026 | 637.18M |
| March 31, 2026 | 614.57M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Mineralys Therapeutics, Inc. | 1.313B |
| Evommune, Inc. | 535.67M |
| Arrowhead Pharmaceuticals, Inc. | 9.517B |
| Oncolytics Biotech, Inc. | 87.93M |
| Sangamo Therapeutics, Inc. | 53.47M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -60.67M |
| Total Expenses (Quarterly) | 60.67M |
| EPS Diluted (Quarterly) | -1.342 |
| Earnings Yield | -14.92% |
| Normalized Earnings Yield | -14.92 |